Collegium Pharmaceutical Inc (COLL) Wheel Strategy

Running a COLL wheel strategy lets you generate consistent premium income on Collegium Pharmaceutical Inc while setting your own entry and exit prices on the underlying. Collegium Pharmaceutical Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own COLL, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best COLL wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on COLL, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable COLL wheel from a losing one.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the COLL wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your COLL wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.